# S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma

> **NCT00107419** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 75 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** pemetrexed disodium

## Key facts

- **NCT ID:** NCT00107419
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-05
- **Final completion:** 2009-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107419, "S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00107419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*